162 related articles for article (PubMed ID: 26335936)
21. External quality assessment for EGFR mutations in Italy: improvements in performances over the time.
Normanno N; Fenizia F; Castiglione F; Barberis M; Taddei GL; Truini M; De Rosa G; Pinto C; Marchetti A
ESMO Open; 2017; 2(2):e000160. PubMed ID: 29181190
[TBL] [Abstract][Full Text] [Related]
22. [Detection of RAS genes mutation using the Cobas
Albertini AF; Raoux D; Neumann F; Rossat S; Tabet F; Pedeutour F; Duranton-Tanneur V; Kubiniek V; Vire O; Weinbreck N
Bull Cancer; 2017; 104(7-8):662-674. PubMed ID: 28688743
[TBL] [Abstract][Full Text] [Related]
23. Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
Harlé A; Filhine-Tresarrieu P; Husson M; Boidot R; Rouyer M; Dubois C; Leroux A; Merlin JL
Target Oncol; 2016 Jun; 11(3):363-70. PubMed ID: 26661077
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
[TBL] [Abstract][Full Text] [Related]
25. Clinical implementation of KRAS testing in metastatic colorectal carcinoma: the pathologist's perspective.
Ross JS
Arch Pathol Lab Med; 2012 Oct; 136(10):1298-307. PubMed ID: 22272560
[TBL] [Abstract][Full Text] [Related]
26. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
27. How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation.
Richman SD; Fairley J; Butler R; Deans ZC
J Clin Pathol; 2017 Jan; 70(1):58-62. PubMed ID: 27681846
[TBL] [Abstract][Full Text] [Related]
28. KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.
Weichert W; Schewe C; Lehmann A; Sers C; Denkert C; Budczies J; Stenzinger A; Joos H; Landt O; Heiser V; Röcken C; Dietel M
J Mol Diagn; 2010 Jan; 12(1):35-42. PubMed ID: 20007841
[TBL] [Abstract][Full Text] [Related]
29. KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.
Dijkstra JR; Heideman DA; Meijer GA; Boers JE; 't Hart NA; Diebold J; Hirschmann A; Hoefler G; Winter G; Miltenberger-Miltenyi G; Pereira SV; Richman SD; Quirke P; Rouleau EL; Guinebretiere JM; Tejpar S; Biesmans B; van Krieken JH
Virchows Arch; 2013 Jan; 462(1):39-46. PubMed ID: 23242173
[TBL] [Abstract][Full Text] [Related]
30. Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.
Patton S; Normanno N; Blackhall F; Murray S; Kerr KM; Dietel M; Filipits M; Benlloch S; Popat S; Stahel R; Thunnissen E
Br J Cancer; 2014 Jul; 111(2):413-20. PubMed ID: 24983368
[TBL] [Abstract][Full Text] [Related]
31. Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.
Kim KP; Kim JE; Hong YS; Ahn SM; Chun SM; Hong SM; Jang SJ; Yu CS; Kim JC; Kim TW
Cancer Res Treat; 2017 Jan; 49(1):161-167. PubMed ID: 27384156
[TBL] [Abstract][Full Text] [Related]
32. KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015.
Jouini R; Ferchichi M; BenBrahim E; Ayari I; Khanchel F; Koubaa W; Saidi O; Allani R; Chadli-Debbiche A
Heliyon; 2019 Mar; 5(3):e01330. PubMed ID: 30949599
[TBL] [Abstract][Full Text] [Related]
33. Molecular testing in metastatic colorectal adenocarcinoma cytology cell pellets.
McHugh KE; Dermawan JK; Cheng YW; Cruise M; Sohal DPS; Reynolds JP
Diagn Cytopathol; 2019 Nov; 47(11):1132-1137. PubMed ID: 31290252
[TBL] [Abstract][Full Text] [Related]
34. High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.
Tol J; Dijkstra JR; Vink-Börger ME; Nagtegaal ID; Punt CJ; Van Krieken JH; Ligtenberg MJ
J Cell Mol Med; 2010 Aug; 14(8):2122-31. PubMed ID: 19453520
[TBL] [Abstract][Full Text] [Related]
35. Results of the UK NEQAS for Molecular Genetics reference sample analysis.
Richman SD; Fairley J; Hall JA; Nataraj N; Bhide M; Lau A; Norman KL; Deans ZC
J Clin Pathol; 2018 Nov; 71(11):989-994. PubMed ID: 30030291
[TBL] [Abstract][Full Text] [Related]
36. Development and Analytical Validation of a DNA Dual-Strand Approach for the US Food and Drug Administration-Approved Next-Generation Sequencing-Based Praxis Extended RAS Panel for Metastatic Colorectal Cancer Samples.
Udar N; Iyer A; Porter M; Haigis R; Smith S; Dhillon S; Meier K; Ward D; Lu J; Wenz P; Buchner L; Dunn T; Wise A; Mueller A; Gutekunst K
J Mol Diagn; 2020 Feb; 22(2):159-178. PubMed ID: 31837434
[TBL] [Abstract][Full Text] [Related]
37. International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.
Keppens C; Dequeker EMC; Patton SJ; Normanno N; Fenizia F; Butler R; Cheetham M; Fairley JA; Williams H; Hall JA; Schuuring E; Deans ZC;
BMC Cancer; 2018 Aug; 18(1):804. PubMed ID: 30092778
[TBL] [Abstract][Full Text] [Related]
38. RAS testing in metastatic colorectal cancer: advances in Europe.
Van Krieken JH; Rouleau E; Ligtenberg MJ; Normanno N; Patterson SD; Jung A
Virchows Arch; 2016 Apr; 468(4):383-96. PubMed ID: 26573425
[TBL] [Abstract][Full Text] [Related]
39. Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial.
Richman SD; Adams R; Quirke P; Butler R; Hemmings G; Chambers P; Roberts H; James MD; Wozniak S; Bathia R; Pugh C; Maughan T; Jasani B;
J Clin Pathol; 2016 Jan; 69(1):35-41. PubMed ID: 26350752
[TBL] [Abstract][Full Text] [Related]
40. Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys.
Keppens C; Schuuring E; Dequeker EMC
Virchows Arch; 2021 May; 478(5):995-1006. PubMed ID: 33225398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
